Premium
Cancer Theranostics: Facile Preparation of Doxorubicin‐Loaded Upconversion@Polydopamine Nanoplatforms for Simultaneous In Vivo Multimodality Imaging and Chemophotothermal Synergistic Therapy (Adv. Healthcare Mater. 4/2015)
Author(s) -
Liu Fuyao,
He Xiuxia,
Lei Zhen,
Liu Liang,
Zhang Junping,
You Hongpeng,
Zhang Huimao,
Wang Zhenxin
Publication year - 2015
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201570021
Subject(s) - photothermal therapy , materials science , in vivo , doxorubicin , nanotechnology , polyethylene glycol , nanoparticle , surface modification , peg ratio , drug delivery , biomedical engineering , medicine , chemotherapy , chemistry , surgery , microbiology and biotechnology , biology , organic chemistry , finance , economics
On page 559, H. M. Zhang, Z. X. Wang, and colleagues directly coat polydopamine (PDA) on hydrophobic upconversion nanoparticle (UCNP) to form UCNP@PDA core–shell nanosphere via a microemulsion approach, further modified with polyethylene glycol (PEG). After loading with DOX, the UCNP@PDA‐PEG‐DOX can completely eradicate mouse‐bearing colorectal cancer without regrowth guided by multimodal imaging, demonstrating highly effective combined photothermal and chemotherapy of the nanocomposites.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom